Skip to main content
Top

30-11-2016 | Juvenile idiopathic arthritis | Book Chapter | Article

5. Epidemiology of Pediatric Rheumatic Diseases

Author: Prudence J. Manners

Publisher: Springer Singapore

Abstract

To learn about the relevance of epidemiology in paediatric rheumatology (PR)
Literature
1.
Fink CW. Proposal for the development of classification criteria for idiopathic arthritis of childhood [see comments] [published erratum appears in J Rheumatol 1995 Nov;22 (11):2195]. J Rheumatol. 1995;22:1566–9.PubMed
2.
Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–2.PubMed
3.
Andersson Gare B, Fasth A. Epidemiology of juvenile chronic arthritis in south-western Sweden: a 5-year prospective population study. Pediatrics. 1992;90:950–8.
4.
Mielants H, Veys EM, Maertens M, et al. Prevalence of inflammatory rheumatic diseases in an adolescent urban student population, age 12 to 18, in Belgium. Clin Exp Rheumatol. 1993;11:563–7.PubMed
5.
Oen K, Fast M, Postl B. Epidemiology of juvenile rheumatoid arthritis in Manitoba, Canada, 1975–92: cycles in incidence. J Rheumatol. 1995;22:745–50.PubMed
6.
Arguedas O, Porras O, Fasth A. Juvenile chronic arthritis in Costa Rica. A pilot referral study. Clin Exp Rheumatol. 1995;13:119–23.PubMed
7.
Malleson P, Fung MY, Rosenberg AM. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol. 1996;23:1981–7.PubMed
8.
Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Dermatol. 1995;34:732–6.
9.
Peterson LS, Mason T, Nelson AM, O’Fallon WM, Gabriel SE. Juvenile rheumatoid arthritis in Rochester, Minnesota 1960–1993. Is the epidemiology changing? Arthritis Rheum. 1996;39:1385–90.CrossRefPubMed
10.
Kaipiainen-Seppanen O, Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980–1990. Clin Exp Rheumatol. 1996;14:441–4.PubMed
11.
Manners PJ, Diepeveen DA. Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia. Pediatrics. 1996;98:84–90.PubMed
12.
Fujikawa S, Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn. 1997;39:242–4.CrossRefPubMed
13.
Ozen S, Karaaslan Y, Ozdemir O, et al. Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1998;25:2445–9.PubMed
14.
Moe N, Rygg M. Epidemiology of juvenile chronic arthritis in northern Norway: a ten- year retrospective study. Clin Exp Rheumatol. 1998;16:99–101.PubMed
15.
Kiessling U, Doring E, Listing J, et al. Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980–88. J Rheumatol. 1998;25:1837–43.PubMed
16.
Arguedas O, Fasth A, Andersson-Gare B, Porras O. Juvenile chronic arthritis in urban San Jose, Costa Rica: a 2 year prospective study. J Rheumatol. 1998;25:1844–50.PubMed
17.
Huang J-L, Yao T-C, See L-C. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Pediatr Rheumatol. 2004;22:776–80.
18.
Hanova P, Pavelka K, Dostal C, et al. Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002–2003. Clin Exp Rheumatol. 2006;24:499–507.PubMed
19.
Danner S, Sordet C, Terzic J, et al. Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol. 2006;33:1377–81.PubMed
20.
Kurahara D, Grandinetti L, Fujii L, Tokuda A, et al. Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas. J Rheumatol. 2007;34:425–9.PubMed
21.
Martinez-Minguel L, Fernandez Menendez J, Soli Sanchez G, et al. Epidemiological study of juvenile idiopathic arthritis in the last sixteen years in Asturias (Spain). An Pediatr. 2007;66:24–30.CrossRef
22.
Solau-Gervais E, Robin C, Gambert C, et al. Prevalence and distribution of juvenile idiopathic arthritis in a region of Western France. Joint Bone Spine. 2010;77:47–9.CrossRefPubMed
23.
Modesto C, Anton J, Rodriguez B, et al. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol. 2010;39:472–9.CrossRefPubMed
24.
Azam S, Dipti T, Rahman S. Prevalence and clinical pattern of juvenile idiopathic arthritis in a semi-urban area of Bangladesh. Int J Rheum Dis. 2012;15:116–20.CrossRefPubMed
25.
Harrold L, Salman C, Shoor S, et al. Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996–2009. J Rheumatol. 2013;40:1218–25.CrossRefPubMed
26.
Abujam B, Mishra R, Aggarwal A. Prevalence of musculoskeletal complaints and juvenile idiopathic arthritis in children from a developing country: a school-based study. Int J Rheum Dis. 2014;17:256–60.CrossRefPubMed
27.
Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2014;81:112–7.CrossRefPubMed
28.
Manners PJ. Delay in diagnosis of juvenile arthritis. Med J Aust. 1999;171:367–9.PubMed
29.
Andersson-Gare B. Juvenile arthritis – who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol. 1999;17:367–74.PubMed
30.
Martini A. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis. 2012;71:1437–9.CrossRefPubMed
31.
Saurenmann R, Rose J, Tyrrell P, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort. Arthritis Rheum. 2007;56(6):1974–84.CrossRefPubMed
32.
Gare BA. Epidemiology of rheumatic disease in children. Curr Opin Rheumatol. 1996;8:449–54.CrossRefPubMed
33.
Martini A. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? J Rheumatol. 2003;30:1900–3.PubMed
34.
Ferrell E, Ponder L, Minor L, et al. Limitations in the classification of childhood-onset rheumatoid arthritis. J Rheumatol. 2014;41:547–53.CrossRefPubMed
35.
van den Broek T, Hoppenreijs E, Meerding J, et al. Cytokine profiling at disease onset: support for classification of young antinuclear antibody-positive patients as a separate category of juvenile idiopathic arthritis. Ann Rheum Dis. 2015;74:470–2.CrossRefPubMed
36.
Manners PJ, Lesslie J, Speldewinde D, Tunbridge D. Classification of juvenile idiopathic arthritis: should family history be included in the criteria? J Rheumatol. 2003;30:1857–63.PubMed
37.
D’Cruz DP, Khamashta MA, Hughes GRV. Systemic lupus erythematosus. Lancet. 2007;369:587–96.CrossRefPubMed
38.
Danchenko N, Satia LA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15:308–18.CrossRefPubMed
39.
Hiraki LT, Menseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman E. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol. 2009;36:2539–46.CrossRefPubMed
40.
Lau C, Yin G, Mok MY. Ethnic and geographical differences in systemic lupus erythematosus: an overview. Lupus. 2006;15:715–9.CrossRefPubMed
41.
McCarty DJ, Manzi S, Medsger T, Ramsey-Goldman R, LaPorte R, Kwoh C. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum. 1995;38:1260–70.CrossRefPubMed
42.
Hom G, Graham G, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358:900–9.CrossRefPubMed
43.
Dozmorov M, Wren J, Alarcon-Riquelme M. Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes. Epigenetics Off J DNA Methylation Soc. 2014;9:276–85.CrossRef
44.
Mendez E, Lipton R, Ramsey-Goldman R, et al. US Incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Disease Registry. Arthritis Rheum. 2003;49:300–5.CrossRefPubMed
45.
Cervera R, Piette J, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–27.CrossRefPubMed
46.
Myones B. Update on antiphospholipid syndrome in children. Curr Rheumatol Rep. 2011;13:86–9.CrossRefPubMed
47.
Gunnarsson R, Gran JT, et al. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011;70:1047–51.CrossRefPubMed
48.
Burdt M, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42:899–909.CrossRefPubMed
49.
Michels H. Course of mixed connective tissue disease in children. Ann Med. 1997;29:359–64.CrossRefPubMed
50.
Tizard E, Hamilton-Ayres M. Henoch-Schonlein purpura. Arch Dis Child Educ Pract Ed. 2007;93:1–8.CrossRef
51.
Gardner-Medwin JMM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schonlein Purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360:1197–202.CrossRefPubMed
52.
Mason W, Takahashi M. Kawasaki syndrome. Clin Infect Dis. 1999;28:169–85.CrossRefPubMed
53.
Yim D, Curtis N, Cheung M, Burgner D. Update on Kawasaki disease: epidemiology, aetiology and pathogenesis. J Paediatr Child Health. 2012;49:704–8.CrossRef
54.
Chang C-J, Kuo H-C, Chang J-S, et al. Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One. 2013;8:e72037.CrossRefPubMedPubMedCentral
55.
Gedalia A. Kawasaki disease: 40 years after the original report. Curr Rheumatol Rep. 2007;9:336–41.CrossRefPubMed
56.
Holman R, Curns A, Belay E, et al. Kawasaki syndrome hospitalisation in the United States. Pediatrics. 2003;112:495–501.CrossRefPubMed